Skip to content

Avanos Medical AVNS Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Stryker logo
StrykerSYK
Cardinal Health logo
Cardinal HealthCAH
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
IAR
Integra LifeSciencesIART

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B-1.2%
Enterprise value$1.24B+3.0%
P/S1.6×-0.1×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's deferred tax assets and other non-current assets?
Avanos Medical (AVNS) reported deferred tax assets and other non-current assets of $32.9M in Q1 2026.
How has Avanos Medical's deferred tax assets and other non-current assets changed year-over-year?
Avanos Medical's deferred tax assets and other non-current assets increased by 29.5% year-over-year, from $25.4M to $32.9M.
What is the long-term trend for Avanos Medical's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Avanos Medical's deferred tax assets and other non-current assets has grown at a 21.7% compound annual growth rate (CAGR), from $11.8M to $31.5M.